Rabeprazole and Domperidone Capsules | Rabnote-DSR

Rabeprazole and Domperidone Capsules

Dosage Form: Capsule

Rabeprazole and Domperidone Capsules are a combination formulation containing Rabeprazole Sodium (EC) and Domperidone (SR). Rabnote-DSR is designed to support the management of acid-related digestive conditions through two ingredients with different mechanisms of action. This oral capsule formulation is available in a pack of 10 × 10 capsules for convenient dispensing and prescribed use.

Rabeprazole works by reducing gastric acid production through the inhibition of acid-secreting proton pumps in the stomach lining. This action helps manage excessive stomach acid and supports the treatment of conditions associated with acid reflux and heartburn.

Domperidone is a prokinetic medicine that helps improve stomach movement and gastric emptying. It also acts on dopamine receptors involved in nausea and vomiting. Its sustained-release formulation is designed to provide prolonged release of the ingredient, according to the formulation characteristics.

Rabeprazole and Domperidone Capsules may be prescribed for selected acid-related digestive conditions, including gastroesophageal reflux and associated symptoms such as nausea, when considered appropriate by a healthcare professional. The combination addresses gastric acid production and gastrointestinal motility through complementary actions.

Rabnote-DSR Capsules should be taken according to the prescribed dosage and administration instructions. Patients should inform their healthcare professional about existing heart or liver conditions, allergies and other medicines they are taking. Domperidone requires particular attention because of its potential to affect heart rhythm. Medical supervision is important for appropriate treatment selection and monitoring.

Category: Brand:

Description

MORE DETAILS ABOUT PRODUCT

  • Primary Use: Prescribed for managing selected acid-related digestive conditions.

  • How It Works: Combines an acid-reducing medicine with a prokinetic agent.

  • Acid Reduction: Rabeprazole reduces gastric acid secretion by inhibiting proton pumps.

  • Prokinetic Action: Domperidone helps improve gastrointestinal movement and gastric emptying.

  • Nausea Management: Domperidone may help manage nausea and vomiting when prescribed.

  • Acid Reflux Management: May be prescribed for gastroesophageal reflux disease (GERD).

  • Heartburn Management: Helps control symptoms associated with excessive stomach acid.

  • Combination Formulation: Contains Rabeprazole Sodium and Domperidone.

  • Enteric-Coated Formulation: Rabeprazole is labelled as EC (enteric-coated).

  • Sustained-Release Formulation: Domperidone is labelled as SR (sustained-release).

Indications

Rabnote-DSR

Key Benefits of Rabnote-DSR Capsules

  • Dual-Action Formulation: Combines Rabeprazole and Domperidone to address different aspects of acid-related digestive symptoms.

  • Acid Secretion Control: Rabeprazole helps reduce excessive gastric acid production.

  • Proton Pump Inhibition: Works by inhibiting acid-secreting proton pumps in the stomach.

  • Prokinetic Support: Domperidone helps improve gastrointestinal movement.

  • Gastric Emptying Support: Supports the movement of stomach contents into the intestine.

  • Acid Reflux Management: May help manage symptoms associated with gastroesophageal reflux.

  • Heartburn Symptom Management: Helps control acid-related heartburn when prescribed.

  • Nausea Management: Domperidone may help manage nausea and vomiting.

  • Complementary Ingredients: Combines two ingredients with different mechanisms of action.

  • Enteric-Coated Rabeprazole: The EC formulation is designed to protect the ingredient during passage through the stomach.

  • Sustained-Release Domperidone: The SR formulation is designed for prolonged release of the ingredient.

  • Digestive Symptom Management: May support the management of selected acid-related digestive complaints.

  • Oral Administration: Provides a convenient capsule dosage form.

  • Combination Therapy: Brings acid-reducing and prokinetic components together in one product.

  • Established Active Ingredients: Contains Rabeprazole Sodium and Domperidone.

  • Convenient Pack Size: Available in a 10 × 10 capsule presentation.

  • Prescription-Based Treatment: Allows healthcare professionals to select treatment according to individual medical requirements.

  • Clinical Treatment Support: Can be included in an appropriate treatment plan following medical evaluation.

  • Targeted Acid Control: Rabeprazole acts on the stomach’s acid-secreting proton pumps.

  • Gastrointestinal Motility Support: Domperidone contributes to the regulation of stomach movement.

Reviews

There are no reviews yet.

Be the first to review “Rabeprazole and Domperidone Capsules | Rabnote-DSR”

Your email address will not be published. Required fields are marked *